325 related articles for article (PubMed ID: 16086735)
1. Thalidomide: dermatological indications, mechanisms of action and side-effects.
Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide and its dermatologic uses.
Moraes M; Russo G
Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
[TBL] [Abstract][Full Text] [Related]
3. Innovative uses of thalidomide.
Chen M; Doherty SD; Hsu S
Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
[TBL] [Abstract][Full Text] [Related]
4. [Current therapeutic indications of thalidomide and lenalidomide].
Ordi-Ros J; Cosiglio FJ
Med Clin (Barc); 2014 Apr; 142(8):360-4. PubMed ID: 23830554
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide: an experience in therapeutic outcome and adverse reactions.
Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
[TBL] [Abstract][Full Text] [Related]
6. A review of thalidomide's history and current dermatological applications.
Perri AJ; Hsu S
Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide experience of a major Australian teaching hospital.
Crouch RB; Foley PA; Ng JC; Baker CS
Australas J Dermatol; 2002 Nov; 43(4):278-84. PubMed ID: 12423435
[TBL] [Abstract][Full Text] [Related]
8. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.
Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
J Am Acad Dermatol; 1996 Dec; 35(6):969-79. PubMed ID: 8959957
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide and its dermatologic uses.
Paghdal KV; Schwartz R
Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide in leprosy and some dermatological conditions--a review.
Parikh DA; Maniar JK; Ganapati R
Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010
[No Abstract] [Full Text] [Related]
11. Thalidomide: current and potential clinical applications.
Calabrese L; Fleischer AB
Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
[TBL] [Abstract][Full Text] [Related]
12. Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome.
Zhang L; Au S; Aronson IK
Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526013
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide: a re-look.
Grover JK; Vats V; Gopalakrishna R; Ramam M
Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide and its impact in dermatology.
Stirling DI
Semin Cutan Med Surg; 1998 Dec; 17(4):231-42. PubMed ID: 9859910
[TBL] [Abstract][Full Text] [Related]
15. Drug survival of thalidomide for dermatological conditions: A single-centre review.
Arasu A; Lee S; Chian Yeoh A; Ross G
Australas J Dermatol; 2021 Feb; 62(1):e107-e109. PubMed ID: 32627846
[No Abstract] [Full Text] [Related]
16. A case series of 48 patients treated with thalidomide.
Doherty SD; Hsu S
J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
[TBL] [Abstract][Full Text] [Related]
17. [Thalidomide in dermatology].
Hunziker T; Krebs A
Hautarzt; 1983 Feb; 34(2):66-72. PubMed ID: 6841082
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide: new preparation. For well-defined indications.
Prescrire Int; 1998 Oct; 7(37):131-4. PubMed ID: 10848043
[TBL] [Abstract][Full Text] [Related]
19. Review of thalidomide use in the pediatric population.
Yang CS; Kim C; Antaya RJ
J Am Acad Dermatol; 2015 Apr; 72(4):703-11. PubMed ID: 25617013
[TBL] [Abstract][Full Text] [Related]
20. [Thalidomide: an eclectic medication in dermatology].
Proença NG
Rev Paul Med; 1989; 107(1):41-6. PubMed ID: 2694291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
